Repligen (RGEN) FCF Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 379.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 183.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 847.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -537.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 876.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -237.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -62.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 164.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 86.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 600.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.00 |
| Mar 31, 2026 | 538.00 |
| Dec 31, 2025 | -1,121.00 |
| Sep 30, 2025 | -435.00 |
| Jun 30, 2025 | -1,174.00 |
| Mar 31, 2025 | -1,697.00 |
| Dec 31, 2024 | 929.00 |
| Sep 30, 2024 | 549.00 |
| Jun 30, 2024 | 706.00 |
| Mar 31, 2024 | 2,214.00 |
| Dec 31, 2023 | -1,140.00 |
| Sep 30, 2023 | 712.00 |
| Jun 30, 2023 | 668.00 |
| Mar 31, 2023 | 358.00 |
| Dec 31, 2022 | 1,281.00 |
| Sep 30, 2022 | 822.00 |
| Jun 30, 2022 | -318.00 |
| Mar 31, 2022 | -316.00 |
| Dec 31, 2021 | 618.00 |
| Sep 30, 2021 | -1,233.00 |